Competitive Grants Program Application Period to Begin on May 20, 2021
DUBLIN, May 13, 2021 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) today announced that the company will begin accepting applications for its Alkermes Inspiration Grants® program beginning on May 20, 2021. Now in its fifth year, this competitive grants program will provide up to a total of $500,000 in grants to assist nonprofit organizations in their work to address the needs of people living with addiction, serious mental illness or cancer.
Fast Company awards seek out ingenuity, impact, and passion to solve world problems
Unprecedented pandemic response. First-of-its-kind heart technology. And innovation in reducing certain heart surgery-related infections. All of these Medtronic healthcare innovations are among the 2021 World Changing Ideas recognized on May 4, 2021 by Fast Company.
New Outcomes Research in Patients With Schizophrenia or Bipolar I Disorder to be Presented
DUBLIN, May 4, 2021 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) recently announced plans to present clinical data and outcomes research from its psychiatry portfolio at three scientific conferences during Mental Health Awareness Month in May. The meetings, all held virtually, include:
Alongside the The STARR Coalition, we recognize the need to support mental health research. Scientific, evidence-based mental health research is essential. To learn more about our commitment to supporting mental health clinical research and how to take actionable steps, visit: https://bit.ly/3bSkreC
As COVID-19 began to spread around the world, Gilead employees worked around the clock to advance the company’s investigational antiviral.
In the next episode of our “Possible” series, meet Laura Bauer, a scientist in the company’s Formulation and Process Development group. Learn how she worked with her team, colleagues at Gilead, and partners across a wide manufacturing and supply chain network to expand production.
The partnership between TechsoMed and Lenovo is enabling physicians to target cancer with never before seen precision.
To treat cancerous tumors, physicians have long relied on surgery, chemotherapy and radiation — highly invasive treatments that push patients’ bodies to their limits. Surgically removing tumors requires long hospital stays, recovery times and extensive follow-ups. In the near future, all of this might change.
Dr. Zoltan Takacs uses a ThinkPad to analyze some of the world's deadliest toxins and turn them into medicine leads.
Most people avoid venomous creatures. Dr. Zoltan Takacs has spent his life chasing them.
The renowned scientist and explorer seeks out the venoms of some of the world’s deadliest creatures — snakes, spiders, scorpions and more — with the hope that their lethal toxins will provide a template for designing new medicines. The basic logic behind his method: What can kill you just might save your life.